Health-care companies fell as traders rotated into more rate-sensitive sectors.
Novo Nordisk shares gave back some of their recent gains, but remain about 30% higher for the year to date. Novo's obesity-drug rival Eli Lilly tapped Amazon.com's pharmacy unit to deliver some of its prescription meds, including its weight-loss drug and migraine treatment.
Heron Therapeutics shares surged after fourth-quarter earnings topped analysts' average expectation.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-13-24 1741ET
